$0.155 -0.0 -6.1%
Last Trade - 26/02/21
| Market Cap | £24.7m |
| Enterprise Value | £22.9m |
| Revenue | £1.48m |
| Position in Universe | 5730th / 6715 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.11 | 0.13 | 0.28 | 0.52 | 1.36 | 1.86 | +75.6% | ||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
BioLargo, Inc. is a technology developer and environmental engineering company. The Company invents, develops, and commercializes platform technologies to eliminate environmental problems like polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater treatment, industrial odor and Volatile organic compounds (VOC) control, air quality control, and infection control. It provides sustainable solutions for a range of industries and applications. The Company’s products include Advanced Oxidation System (AOS), Aqueous Electrostatic Concentrator, CupriDyne Clean Industrial Odor and VOC Eliminator, and Clyra Advanced Wound Care Products. The Company provides its products through its subsidiaries, including ONM Environmental, Inc; BioLargo Water, Inc; BioLargo Engineering, Science & Technologies, LLC; and Clyra Medical Technologies, Inc.
| Last Annual | December 31st, 2019 |
| Last Interim | September 30th, 2020 |
| Incorporated | September 19, 1991 |
| Public Since | December 12, 1991 |
| No. of Shareholders: | n/a |
| No. of Employees: | 9 |
| Sector | Basic Materials |
| Industry | Chemicals |
| Index | |
| Exchange | Pink Sheets on Nasdaq |
| Shares in Issue | 222,395,857 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 14921 Chestnut St, WESTMINSTER, 92683-5215, United States |
| Web | http://biolargo.com/ |
| Phone | +1 949 6439540 |
| Contact | () |
| Auditors | Haskell & White LLP |
As of 26/02/21, shares in BioLargo Inc are trading at $0.155, giving the company a market capitalisation of £24.7m. This share price information is delayed by 15 minutes.
Shares in BioLargo Inc are currently trading at $0.155 and the price has moved by -26.19% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the BioLargo Inc price has moved by -43.67% over the past year.
There are no analysts currently covering BioLargo Inc.
BioLargo Inc is scheduled to issue upcoming financial results on the following dates:
BioLargo Inc does not currently pay a dividend.
BioLargo Inc does not currently pay a dividend.
BioLargo Inc does not currently pay a dividend.
To buy shares in BioLargo Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in BioLargo Inc are currently trading at $0.155, giving the company a market capitalisation of £24.7m.
Here are the trading details for BioLargo Inc:
Based on an overall assessment of its quality, value and momentum, BioLargo Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We were not able to load any forecast data for BioLargo Inc.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BioLargo Inc. Over the past six months, the relative strength of its shares against the market has been -25.73%. At the current price of $0.155, shares in BioLargo Inc are trading at -3.6% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for BioLargo Inc.
BioLargo Inc's management team is headed by:
Here are the top five shareholders of BioLargo Inc based on the size of their shareholding:
